Physician profile
Cheryl Smith
NPI 1982330619
$733.42
in general payments reported to CMS, 2019-2025
13 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $99.35 · 2024: $393 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $155.23 | 2023-2024 | |
| Tolmar, INC. | $144.43 | 2024-2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $60.82 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $57.18 | 2024-2025 | Ams 800 Artificial Urinary Sphincter, Axonics |
| Endo Pharmaceuticals INC. | $47.74 | 2023-2024 | Xiaflex, Aveed |
| Astellas Pharma US INC | $43.29 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.09 | 2023-2024 | |
| Pfizer INC. | $39.52 | 2024-2025 | |
| Dentsply Ih Ab | $37.71 | 2025 | Lofric |
| 180 Medical, INC. | $29.26 | 2025 | Gentlecath |
| Ambu INC. | $28.52 | 2024 | |
| Endo USA, INC. | $24.74 | 2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $23.89 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.